Various lysates were subjected to SDS PAGE followed by western blot with CL594-66009 (Beta Actin antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

---

1X10^6 A431 cells were intracellularly stained with 0.8 ug CoraLite®594 Anti-Human Beta Actin (CL594-66009, Clone:2D4H5) (red), or 0.8 ug Control Antibody. Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---

Immunofluorescent analysis of (-20°C Methanol) fixed MDCK cells using CoraLite®594 Beta Actin antibody (CL594-66009, Clone: 2D4H5 ) at dilution of 1:200.

---

Immunofluorescent analysis of (-20°C Methanol) fixed HepG2 cells using CoraLite®594 Beta Actin antibody (CL594-66009, Clone: 2D4H5 ) at dilution of 1:200.

---

Immunofluorescent analysis of (-20°C Ethanol) fixed HepG2 cells using CL594-60330 (Vimentin antibody) at dilution of 1:100.

---

1X10^6 HeLa cells were intracellularly stained with 0.4 ug CoraLite®594 Anti-Human Vimentin (CL594-60330, Clone:3H9D1) (red), or 0.4 ug Control Antibody. Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---

Immunofluorescent analysis of (-20°C Methanol) fixed HepG2 cells using CoraLite®488 Vimentin antibody (CL488-60330, Clone: 3H9D1 ) at dilution of 1:400.

---

1X10^6 Jurkat cells were intracellularly stained with 0.4 ug CoraLite®488 Anti-Human Vimentin (CL488-60330, Clone:3H9D1) (red), or 0.4 ug Mouse IgG1 Isotype Control (CL488-66360, Clone: T1F8D3F10) (blue). Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---

Immunofluorescent analysis of (-20°C Methanol) fixed HepG2 cells using CoraLite®488 Vimentin antibody (CL488-60330, Clone: 3H9D1 ) at dilution of 1:400.

---

1X10^6 Jurkat cells were intracellularly stained with 5 ul CoraLite® Plus 647 Anti-Human CD107b (CL647-65053, Clone:H4B4) (red) or Control Antibody. Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---

Immunofluorescent analysis of (-20°C Ethanol) fixed HeLa cells using CoraLite® Plus 647-conjugated CD107b antibody (CL647-65053, Clone: H4B4) at dilution of 1:50 and CoraLite®488-conjugated CD107a antibody (CL488-65051, Clone: H4A3, green) at dilution of 1:50.

---

Immunofluorescent analysis of (-20°C Ethanol) fixed HeLa cells using CoraLite®594-conjugated CD107a antibody (CL594-65051, Clone: H4A3) at dilution of 1:400. F-actin was stained using CL488-phalloidin (green) and DNA was stained by DAPI (blue).

---

1x10^6 HeLa cells were intracellularly stained with 0.4 ug CoraLite®594 Anti-Human CD107a / LAMP1 (CL594-65051, Clone:H4A3)(red), or 0.4 ug CoraLite®594 Mouse IgG1 Isotype Control (MOPC-21) (CL594-65124, Clone: MOPC-21) (blue). Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---

1X10^6 Jurkat cells were intracellularly stained with 5 ul CoraLite®594 Anti-Human CD107b (CL594-65053, Clone:H4B4) (red) or Control Antibody. Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---

Immunofluorescent analysis of (-20°C Ethanol) fixed HeLa cells using CoraLite®594-conjugated CD107b antibody (CL594-65053, Clone: H4B4) at dilution of 1:50.

---

Immunofluorescent analysis of (4% PFA) fixed HepG2 cells using CoraLite®594 ATP5A1 antibody (CL594-66037, Clone: 1B10H3 ) at dilution of 1:100.

---

Various lysates were subjected to SDS PAGE followed by western blot with CL594-66037 (ATP5A1 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

---

Immunofluorescent analysis of (4% PFA) fixed HeLa cells using PE-Anti-Human CD107a antibody (PE-65051, Clone: H4A3) at dilution of 1:50.

---

1X10^6 HeLa cells were intracellularly stained with 10 ul PE Anti-Human CD107a (PE-65051, Clone:H4A3) (red), or Control Antibody. Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---